Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$18.88 USD
+0.67 (3.68%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $18.92 +0.04 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 1 - 20 ( 117 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4/FY23 Financials; Cas Initial Topline Efficacy; STAR-131 in Periop NSCLC
Provider: Wedbush Securities Inc.
Analyst: ERT V
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Quemli High mOS in mPDAC; Tira in EC Supports Dom in GI
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
RCUS, EXEL to Initiate Ph1b/2 STELLAR-009 of Zanza+AB521 in Solid Tumors, ccRCC
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- SKYSCRAPER, Episode IV: A New Hope
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
SKYSCRAPER: These Aren''t The Droids You''re Looking For
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology -TIGIT Time at ASCO Boosting RCUS and ITOS
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Further II expansion announced with GILD collaboration
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R